secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001104659-26-055887
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q3 revenue down 2% to $311.4M, adj EPS $0.53; declares $0.08 dividend
--------------------------------------------------------------------------------

- Revenue $311.4M, down 2% reported and organic; GAAP EPS $0.32 (up from $0.14), adjusted EPS $0.53 (down from $0.56).
- Large pharma grew double-digits for sixth consecutive quarter; U.S. academic market stabilized with low-single-digit growth; emerging biotech spending still lagging.
- Protein Sciences segment sales $226.2M (down 1% reported); segment margin 44.2% vs 45.6%.
- Diagnostics & Spatial Biology segment sales $85.6M (down 4% reported, up 3% organic); segment margin improved to 12.1% from 9.4%.
- Declared quarterly dividend $0.08 per share, payable May 29, 2026 to shareholders of record May 18, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000110465926055887/0001104659-26-055887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000110465926055887/tech-20260506x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-055887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer